| Literature DB >> 26620576 |
A Hooper1, A Zambon, C J Springer.
Abstract
The one-pot borylation/Suzuki reaction is a very efficient means of accessing cross-coupling products of two aryl-halide partners that generally requires the use of specific catalysts or ligands and/or relatively long reaction times. This new microwave-assisted method provides a quick one-pot borylation/Suzuki reaction protocol that we applied to the synthesis of various bi- or poly-aryl scaffolds, including a variety of aryl and heteroaryl ring systems and the core frameworks of kinase inhibitors vemurafenib and GDC-0879.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26620576 PMCID: PMC4718143 DOI: 10.1039/c5ob01915j
Source DB: PubMed Journal: Org Biomol Chem ISSN: 1477-0520 Impact factor: 3.876
Optimisation of the reaction conditions
|
| |||||||
| Entry | Cat1/base1 |
|
|
| Cat2/Base2 |
|
|
| 1 | Pd(dppf)Cl2/KOAc | 18 | 80 | 100 | Pd(dppf)Cl2/KOAc | 1 | 0 |
| 2 | Pd(dppf)Cl2/KOAc | 18 | 80 | 100 | Pd(PPh3)4/KOAc | 1 | 0 |
| 3 | Pd(dppf)Cl2/KOAc | 1 | 120 | 100 | Pd(PPh3)4/KOAc | 1 | 0 |
| 4 | Pd(PPh3)4/KOAc | 1 | 120 | 100 | Pd(PPh3)4/KOAc | 1 | 0 |
| 5 | Pd(PPh3)4/KOAc | 1 | 120 | 100 | Pd(PPh3)4/Na2CO3(aq) | 1 | 100 |
| 6 | Pd(PPh3)4/Na2CO3(aq) | 1 | 120 | 0 | — | — | — |
| 7 | Pd(PPh3)4/KOAc | 45 min | 120 | 100 | —/Na2CO3(aq) | 30 min | 100 |
Reaction conditions: 1a (1 equiv.), B2(pin)2 (1.2 equiv.), catalyst (10 mol%) and base (3 equiv.) in dioxane (0.5 M) followed by 3a (1 equiv.), catalyst (10 mol%) and base (2 equiv.).
Conversion by LCMS.
Reactions performed in a microwave.
Initially heated to 80 °C over 18 h but after no product 2a formation was observed, it was heated to 120 °C in a microwave for 1 h.
Only indanone dimer observed.
Fig. 1Proposed catalytic cycle.
Scope of reaction to perform basic scaffolds
|
| ||||
| Entry | First halide | Second halide | Product | Yield |
| 1 |
|
|
| 70 |
| 2 |
|
|
| 12 |
| 3 |
|
|
| 67 |
| 4 |
|
|
| 100 |
| 5 |
|
|
| 52 |
| 6 |
|
|
| 53 |
| 7 |
|
|
| 46 |
| 8 |
|
|
| 40 |
| 9 |
|
|
| 42 |
| 10 |
|
|
| 32 |
| 11 |
|
|
| 62 |
| 12 |
|
|
| 49 |
| 13 |
|
|
| 81 |
| 14 |
|
|
| 45 |
| 15 |
|
|
| 87 |
| 16 |
|
|
| 68 |
Reaction conditions: first halide (1 equiv.), B2(pin)2 (1.2 equiv.), Pd(PPh3)4 (10 mol%) and KOAc (3 equiv.) in dioxane (0.5 M) followed by second halide (1 equiv.) and 2 M Na2CO3 (aq) (2 equiv.).
Isolated yield.
Scope of reaction to form complex scaffolds
|
| ||||
| Entry | First halide | Second halide | Product | Yield |
| 1 |
|
|
| 57 |
| 2 |
|
|
| 33 |
| 3 |
|
|
| 49 |
| 4 |
|
|
| 65 |
Reaction conditions: first halide (1 equiv.), B2(pin)2 (1.2 equiv.), Pd(PPh3)4 (10 mol%) and KOAc (3 equiv.) in dioxane (0.4 M) followed by second halide (1 equiv.) and 2 M Na2CO3 (aq) (2 equiv.).
Isolated yield.
Results of kinase screen using a small panel of kinase inhibitor-like scaffolds
|
| ||||||||||||||||||||
| Entry | Compound | Kinase % inhibition | ||||||||||||||||||
| AurA | RSK1 | PRAK | Erk1 | PKD2 | CK1δ | CHK1 | ABL | FYN | LYNα | CHK2 | MET | LCK | SRC | GSK3β | Erk2 | PKACα | INSR | MSK1 | ||
| 1 |
| 51 | 41 | 19 | 14 | 38 | 38 | 10 | 41 | –2 | 33 | 35 | 16 | 31 | 25 | 56 | 14 | 6 | 24 | 28 |
| 2 |
| 76 | –2 | 3 | 16 | 6 | 46 | 15 | 37 | 1 | 20 | 41 | 16 | 16 | 20 | 26 | 19 | –14 | 61 | 4 |
| 3 |
| 60 | 20 | 40 | 8 | 18 | 50 | 13 | 23 | –25 | 24 | 35 | 9 | 29 | 8 | 8 | –7 | 37 | 46 | 19 |
| 4 |
| 61 | 52 | 26 | 7 | 32 | 34 | 0 | 68 | 54 | 63 | 25 | 17 | 61 | 43 | 30 | 10 | 52 | 24 | 42 |
| 5 |
| 89 | 91 | 86 | 55 | 87 | 73 | 6 | 87 | 79 | 30 | 43 | 47 | 16 | 79 | 45 | 53 | 46 | 58 | 69 |
| 6 |
| 45 | 31 | 22 | 6 | 34 | 70 | –9 | 65 | –1 | 29 | 18 | 29 | 43 | 19 | 26 | 1 | 22 | 21 | 13 |
| 7 |
| 7 | 3 | –1 | 0 | –35 | 68 | –7 | 36 | 18 | –7 | 3 | 16 | 11 | 3 | 60 | 3 | 29 | 12 | 13 |
| 8 |
| 51 | 30 | 27 | 8 | 13 | 58 | –12 | 43 | 27 | 46 | 37 | 28 | 18 | 25 | 14 | 4 | 56 | 26 | 26 |
| 9 |
| 99 | 70 | 47 | 62 | 92 | 94 | 80 | 85 | 53 | 76 | 91 | 52 | 63 | 62 | 57 | 66 | 61 | 93 | 43 |
| 10 |
| 45 | 34 | 12 | 7 | 16 | 44 | 1 | 95 | 30 | 49 | 18 | 35 | 54 | 23 | 26 | 1 | 37 | 44 | 15 |
| 11 |
| 66 | 48 | 14 | 6 | 18 | 92 | –1 | 94 | 48 | 64 | 37 | 35 | 67 | 36 | 50 | –7 | 59 | 49 | 24 |
Determination of IC50 and ligand efficiency with ABL for 4o and 4p at compound concentration of 100 μM
| Entry | Compound | ABL IC50 (μM) | Ligand efficiency |
| 1 |
| 8.11 | 0.45 |
| 2 |
| 19.2 | 0.39 |